Skip to main content
CDC Website

Government Agencies

Leaving No One Behind: Community Partnerships in Reducing Hepatitis Disparities

This webinar recording discusses how to reduce disparities in hepatitis, research and community partnerships have been essential in reaching at-risk and underserved populations by addressing the adverse social determinants that are responsible for these disparities. For example, successful collaborations often simplify and facilitate access and linkage to care. In many cases, communities are considered as program recipients or research subjects instead of critical partners who should be significant contributors to the design and implementation of an initiative.

America's HIV Epidemic Analysis Dashboard

AHEAD is "one tool" supporting and/or tracking the Ending the HIV Epidemic in the U.S. (EHE). AHEAD helps track the six EHE indicators in areas with the highest burden of HIV. It complements and serves as one of many important implementation elements of the EHE initiative and the National HIV/AIDS Strategy. This interactive dashboard can be used to inform planning and is a starting place to explore other HIV data sources.

Webinar: ADAP Considerations for the 2024 Plan Year

This webinar provides a refresher for ADAPs on Open Enrollment, as well as relevant policy updates since the last Open Enrollment period, updates about the ongoing "unwinding" of Medicaid continuous coverage protections, and strategies for helping clients obtain and maintain coverage in the 2024 plan year and beyond.

Unlocking Viral Hepatitis Elimination on the African Continent

A webinar from representatives of the Great Lakes Peace Centre, Coalition Against Hepatitis for People of African Origin, and Ubora Foundation that highlights the efforts toward achieving viral hepatitis elimination in Uganda and elsewhere through awareness-raising, and involvement of women, youth, coalitions, community health workers, and others.

Doxycycline for STI PEP: Implementation Toolkit

This toolkit combines existing lessons learned from those clinics already using doxycycline as STI PEP, as well as broader lessons learned from the implementation of other new sexual health biomedical tools, like PrEP for HIV and the Jynneos vaccine for Mpox.

Was this page helpful? Give Feedback